Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statin and Vitamin D for Thyroid Eye Disease
NCT07400757Recruiting
- Sponsor
- Taipei Veterans General Hospital
- Start
- Feb 2026
- Primary completion
- Dec 2029
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of atorvastatin and vitamin d in thyroid eye disease (TED) (4 arms), sponsored by Taipei Veterans General Hospital. Primary endpoints: Clinical Activity Score at 24 weeks, Thyroid Eye Disease Activity Responder Rate at 24 weeks and 2 more. Started Feb 2026; status: recruiting.
02
Drugs
atorvastatinvitamin d
03
Conditions
thyroid eye disease (TED)
Beyond the preview
Go deeper on NCT07400757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07400757.